SK
Sanjay Kukreja Cheturam
About Sanjay Kukreja Cheturam
Data last updated:
Sanjay Kukreja Cheturam is a Director at Adroit Pharmaceuticals Private Limited (since 1997), Director at Haseeb Pharmaceuticals Private Limited (since 2022) and Director at Household Pharmaceuticals Limited (since 2009), and holds 5 more current directorships. The companies operate in Pharma, Information Technology and Chemicals and Materials. The 5 current companies with reported revenue have a combined latest revenue of ₹153 Cr; the largest is Adroit Pharmaceuticals Private Limited at ₹80.51 Cr (FY 2024). Earlier, Sanjay Kukreja Cheturam was a Director at Oasis Infraspace Private Limited (2023–2024) and Director at Imed Pharmaceuticals (India) Private Limited (2014–2015) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Adroit Pharmaceuticals Private Limited U24239MH1977PTC019620 | Director | 10 Mar 1997 | 1977 | ₹80.51 Cr (FY 2024) | Active |
 Haseeb Pharmaceuticals Private Limited U24230MH1999PTC119395 | Director | 14 Mar 2022 | 1999 | ₹66.51 Cr (FY 2025) | Active |
| Household Pharmaceuticals Limited U24230MH1994PLC076735 | Director | 25 Mar 2009 | 1994 | ₹3.70 Cr (FY 2025) | Active |
| L'focus Consultancy Services Private Limited U72300MH2010PTC211537 | Director | 29 Dec 2010 | 2010 | ₹1.69 Cr (FY 2025) | Active |
| Leela Organics Private Limited U24304MH2020PTC347053 | Director | 01 Oct 2020 | 2020 | ₹10 Lakh (FY 2021) | Active |
| Shruthi Infraprojects Private Limited U45202MH2008PTC179095 | Whole-Time Director | 09 Jul 2024 | 2008 | Active | |
| Unijules Injectable Private Limited U24299MH2020PTC341380 | Director | 03 Jul 2020 | 2020 | Active | |
| Heil German Pharmaceuticals Private Limited U24239MH2010PTC209694 | Director | 01 Nov 2010 | 2010 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Oasis Infraspace Private Limited U71100MH2023PTC408542 | Director | 11 Aug 2023 | 2023 | ₹47.8 Lakh (FY 2025) | Active |
| Imed Pharmaceuticals (India) Private Limited U24200KA2008PTC047159 | Director | 30 Sep 2014 | 2008 | ₹7.24 Cr (FY 2015) | Active |
| Hogin Commercials Private Limited U40106MH2010PTC209990 | Director | 12 Nov 2010 | 2010 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjay Kukreja Cheturam
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhimanyu Hassanand Kukreja | 03224925 | Adroit Pharmaceuticals Private Limited | Director |
| Bhupendra Abhimanyu Kukreja | 00868830 | Adroit Pharmaceuticals Private Limited , Haseeb Pharmaceuticals Private Limited and 4 more | Director |
| Cheturam Hassanand Kukreja | 03204583 | Adroit Pharmaceuticals Private Limited | Director |
| Ghanshyamdas Hassanand Kukreja | 03020822 | Adroit Pharmaceuticals Private Limited | Director |
| Kamal Abhimanyu Kukreja | 02166998 | Household Pharmaceuticals Limited | Director |
| Suniya Deepak Kukreja | 02898396 | Household Pharmaceuticals Limited | Director |
| Sangeeta Sanjay Kukreja | 02162463 | L'focus Consultancy Services Private Limited | Director |
| Suvarchala Yerramilli | 01305720 | Shruthi Infraprojects Private Limited | Director |
| Yerramilli Venkata Surya Sanyasi Raju | 01998847 | Shruthi Infraprojects Private Limited | Director |
| Ravindra Kanhaiyalal Kukreja | 03225877 | Unijules Injectable Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Kukreja Cheturam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Kukreja Cheturam
Sanjay Kukreja Cheturam currently holds 8 directorships: Adroit Pharmaceuticals Private Limited (Director, since 10 Mar 1997, revenue ₹80.51 Cr (FY 2024)); Haseeb Pharmaceuticals Private Limited (Director, since 14 Mar 2022, revenue ₹66.51 Cr (FY 2025)); Household Pharmaceuticals Limited (Director, since 25 Mar 2009, revenue ₹3.70 Cr (FY 2025)); L'focus Consultancy Services Private Limited (Director, since 29 Dec 2010, revenue ₹1.69 Cr (FY 2025)); Leela Organics Private Limited (Director, since 01 Oct 2020, revenue ₹10 Lakh (FY 2021)); and 3 more.
Sanjay Kukreja Cheturam was first appointed on 10 Mar 1997 as Director at Adroit Pharmaceuticals Private Limited. The most recent appointment on record is 09 Jul 2024 at Shruthi Infraprojects Private Limited.
The 5 current companies of Sanjay Kukreja Cheturam that report revenue have a combined latest revenue of ₹153 Cr: Adroit Pharmaceuticals Private Limited ₹80.51 Cr (FY 2024); Haseeb Pharmaceuticals Private Limited ₹66.51 Cr (FY 2025); Household Pharmaceuticals Limited ₹3.70 Cr (FY 2025); L'focus Consultancy Services Private Limited ₹1.69 Cr (FY 2025); Leela Organics Private Limited ₹10 Lakh (FY 2021).
Sanjay Kukreja Cheturam held 3 earlier board appointments: Oasis Infraspace Private Limited (Director, 11 Aug 2023 to 11 Aug 2024); Imed Pharmaceuticals (India) Private Limited (Director, 30 Sep 2014 to 31 Mar 2015); Hogin Commercials Private Limited (Director, 12 Nov 2010 to 02 Dec 2011).
The current boards of Sanjay Kukreja Cheturam's companies include Abhimanyu Hassanand Kukreja (Adroit Pharmaceuticals Private Limited), Bhupendra Abhimanyu Kukreja (Adroit Pharmaceuticals Private Limited), Cheturam Hassanand Kukreja (Adroit Pharmaceuticals Private Limited), Ghanshyamdas Hassanand Kukreja (Adroit Pharmaceuticals Private Limited), Kamal Abhimanyu Kukreja (Household Pharmaceuticals Limited), Suniya Deepak Kukreja (Household Pharmaceuticals Limited), among others.